Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Boric Acid SCHEMBL8594563 | 1.00 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL1483674 | 1.00 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL1227700 | 1.00 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL168347 | 1.00 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL11061786 | 1.00 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL36976 | 1.00 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL562566 | 1.00 | — | — | |
| Boric Acid SCHEMBL2793475 | 1.00 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL21951406 | 1.00 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL12054220 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1737871-B1 | METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BOROHYDRIDE AND METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BORANES | SEMEQUIP INC (US) | 2012-10-10 | — | — | EP | claimed |
| US-8084007-B2 | Methods of synthesis of isotropically enriched borohydride and methods of synthesis of isotropically enriched boranes | SEMEQUIP INC. (US) | 2011-12-27 | — | — | US | claimed |
| US-20100111801-A1 | METHODS OF SYNTHESIS OF ISOTROPICALLY ENRICHED BOROHYDRIDE AND METHODS OF SYNTHESIS OF ISOTROPICALLY ENRICHED BORANES | SEMEQUIP INC. (US) | 2010-05-06 | — | — | US | claimed |
| US-7641879-B2 | Methods of synthesis of isotopically enriched borohydride and methods of synthesis of isotopically enriched boranes | SEMEQUIP INC. (US) | 2010-01-05 | — | — | US | claimed |
| EP-1737871-A4 | METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BOROHYDRIDE AND METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BORANES | SEMEQUIP INC (US) | 2009-04-15 | — | — | EP | claimed |
| EP-1737871-A2 | METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BOROHYDRIDE AND METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BORANES | Semequip, Inc. (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2005074531-A2 | METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BOROHYDRIDE AND METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BORANES | SEMEQUIP INC. (US) | 2005-08-18 | — | — | WO | claimed |
| US-20050169827-A1 | Methods of synthesis of isotopically enriched borohydride and methods of synthesis of isotopically enriched boranes | SEMEQUIP INC. | 2005-08-04 | — | — | US | claimed |
| WO-2000055090-A1 | METHOD OF SYNTHESIZING ENRICHED DECABORANE FOR USE IN GENERATING BORON NEUTRON CAPTURE THERAPY PHARMACEUTICALS | LOCKHEED MARTIN IDAHO TECHNOLOGIES COMPANY (US) | 2000-09-21 | — | — | WO | claimed |
| US-6086837-A | Method of synthesizing enriched decaborane for use in generating boron neutron capture therapy pharmaceuticals | BECHTEL BWXT IDAHO, LLC (US) | 2000-07-11 | — | — | US | claimed |
| US-4115521-A | Process for the synthesis of decaborane(14) | UNION CARBIDE CORPORATION (US) | 1978-09-19 | — | — | US | claimed |
| US-4115520-A | Process for the synthesis of tetradecahydroundecaborate compounds | UNION CARBIDE CORPORATION (US) | 1978-09-19 | — | — | US | claimed |
| CN-111868116-B | Ethylene-alpha-olefin-nonconjugated polyene copolymer, process for producing the same, and use thereof | 三井化学株式会社 | 2022-12-09 | — | — | CN | disclosed |
| EP-1737871-B1 | METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BOROHYDRIDE AND METHODS OF SYNTHESIS OF ISOTOPICALLY ENRICHED BORANES | SEMEQUIP INC (US) | 2012-10-10 | — | — | EP | disclosed |
| CN-101001829-B | Method for synthesizing isotopically enriched boron hydride compound and method for synthesizing isotopically enriched borane | SEMEQUIP, INC. (US) | 2012-02-22 | — | — | CN | disclosed |
| CN-101001829-B | Method for synthesizing isotopically enriched boron hydride compound and method for synthesizing isotopically enriched borane | SEMEQUIP, INC. (US) | 2012-02-22 | — | — | CN | disclosed |
| US-4115521-A | Process for the synthesis of decaborane(14) | UNION CARBIDE CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
| US-4115521-A | Process for the synthesis of decaborane(14) | UNION CARBIDE CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
| US-4115520-A | Process for the synthesis of tetradecahydroundecaborate compounds | UNION CARBIDE CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
| US-4115520-A | Process for the synthesis of tetradecahydroundecaborate compounds | UNION CARBIDE CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100111801-A1 | METHODS OF SYNTHESIS OF ISOTROPICALLY ENRICHED BOROHYDRIDE AND METHODS OF SYNTHESIS OF ISOTROPICALLY ENRICHED BORANES | SLC5A11, IPO11, HCN4 | LMNA 2187/4885TSHR 3213/4885TDP1 3023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.